BioLife Solutions Announces Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/25/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
BioLife Solutions (BLFS) PT Raised to $8 at Maxim Group
November 10, 2017 7:53 AM ESTMaxim Group raised its price target on BioLife Solutions (NASDAQ: BLFS) to $8.00 (from $7.00) while maintaining a Buy rating.
Analyst Jason McCarthy notes the company reported 3Q17 with $3.0M in revenue, up 16% sequentially and 39% YoY. Growth continues to be driven by both Cryostor (freezing media)... More
